Myeloma is a malignant and incurable disease of the bone marrow. In up to a fifth of patients it is found by chance.
Our team has vast experience in dealing with myeloma and associated problems at all stages of the disease. We offer a full range of treatment approaches and have an extensive clinical trials portfolio which allows access to newer therapies such as monoclonal antibodies.
We also have an active clinical research programme with particular interest in imaging approaches, diagnostic markers and immunotherapy.
Symptoms of myeloma
- Persistent severe bone pain
- Recurrent infections
- Renal impairment (kidney problems)
- Hypercalcaemia (raised blood calcium levels)
- Abnormal immunoglobulin (antibody) levels
Monocloncal gammopathy of uncertain significance (MGUS)
This is a condition where a low level paraprotein is found in the blood, with no other features to suggest myeloma, although this may later develop in some patients. All patients with MGUS are monitored in our service but most only require a quick consultation and check on paraprotein levels.
Patients with suspected myeloma should be referred urgently through the two week wait referral pathway.
For patients with a low paraprotein (less than 5g/dl) and no symptoms or signs of myeloma, please see the haematology referrals page for more information.
All patients will be seen within four weeks.
This section contains links to relevant external websites, which we hope you will find useful. This does not mean we endorse or accept responsibility for the sites or the information found on them.